Skip to main content
. 2017 Nov 22;99(1):103–108. doi: 10.1099/jgv.0.000875

Fig. 1.

Fig. 1.

PCV1 quantification results after the infectivity assay on BK cells. The PCV1-prototype group (a and b) and the PCV1-GSK group (c and d) were pretreatedwith d-glucosamine (a and c) or not (b and d) before inoculation. m.o.i. ranges from 10 to 0.01 with a mock-infection group which remained negative throughout.